ERG and prostate cancer: Later, mouse xenografts derived from primary tumors, local and distant metastases of fusion-positive prostate cancers were used to study the expression of ERG. All androgen-dependent, fusion-positive xenografts were shown to overexpress ERG, including samples derived from local and distant metastases.